Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,798,493,209
-$344,426,657 QoQ
Shares Held
30,065,642
+1.1% QoQ
Ownership
2.42%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#8
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $76,028,444,777 across 14 Drug Manufacturers - General names. GILD ranks #6 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,310,858 | $24,361,454,441 | |
| 2 | JNJ |
Johnson & Johnson
|
59,086,417 | $15,006,177,324 | |
| 3 | ABBV |
AbbVie Inc.
|
46,998,433 | $11,826,685,679 | |
| 4 | MRK |
Merck & Co., Inc.
|
60,744,214 | $7,805,631,499 | |
| 5 | AMGN |
Amgen Inc
|
15,696,068 | $5,683,860,144 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
30,065,642 | $3,798,493,209 | |
| 7 | PFE |
Pfizer Inc
|
135,275,782 | $3,257,440,829 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
56,443,077 | $3,252,250,096 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,798,493,209 | 30,065,642 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,142,919,866 | 29,726,052 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,644,887,284 | 29,696,002 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $3,322,117,446 | 29,928,986 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,238,253,485 | 29,207,662 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $3,191,200,470 | 28,480,147 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,613,139,632 | 28,289,917 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,309,026,540 | 27,540,870 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,850,168,065 | 26,966,449 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,930,090,253 | 26,349,355 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,047,461,726 | 25,274,185 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,850,691,186 | 24,695,639 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,866,067,856 | 24,212,636 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,971,786,281 | 23,765,051 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,047,391,750 | 23,848,477 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,456,105,528 | 23,603,591 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,432,296,860 | 23,172,575 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,349,733,003 | 22,703,667 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,651,091,787 | 22,739,179 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,557,549,107 | 22,298,484 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,509,089,004 | 21,915,321 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,335,986,506 | 20,671,306 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,169,797,878 | 20,078,920 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,263,924,989 | 20,001,978 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,513,058,568 | 19,665,435 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,486,416,297 | 19,882,508 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||